Nifty
Sensex
:
:
23346.40
74294.96
75.80 (0.33%)
-19.63 (-0.03%)

Pharmaceuticals & Drugs - API

Rating :
70/99

BSE: 500288 | NSE: MOREPENLAB

120.90
18-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  120.6
  •  123.45
  •  118.14
  •  120.56
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  16816327
  •  2028617945.31
  •  123.45
  •  33.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,624.76
  • 47.14
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,750.62
  • 0.17%
  • 5.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.65%
  • 2.19%
  • 49.75%
  • FII
  • DII
  • Others
  • 1.46%
  • 0.95%
  • 10.00%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.73
  • 3.14
  • 2.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.43
  • -1.67
  • -4.56

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.91
  • -1.37
  • -0.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 27.13
  • 28.69
  • 29.70

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.26
  • 2.90
  • 2.85

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.43
  • 16.80
  • 18.17

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
570.13
425.24
34.07%
484.72
465.85
4.05%
484.16
452.78
6.93%
411.58
437.73
-5.97%
Expenses
487.59
401.07
21.57%
460.27
423.61
8.65%
437.84
416.64
5.09%
380.88
393.66
-3.25%
EBITDA
82.53
24.17
241.46%
24.45
42.24
-42.12%
46.32
36.14
28.17%
30.70
44.07
-30.34%
EBIDTM
14.48%
5.68%
5.04%
9.07%
9.57%
7.98%
7.46%
10.07%
Other Income
5.18
4.41
17.46%
8.46
4.61
83.51%
3.81
5.34
-28.65%
4.64
4.99
-7.01%
Interest
4.84
4.04
19.80%
3.88
4.67
-16.92%
4.32
1.34
222.39%
4.18
1.18
254.24%
Depreciation
8.35
9.03
-7.53%
5.75
16.47
-65.09%
10.38
4.93
110.55%
11.28
1.86
506.45%
PBT
74.53
15.52
380.22%
23.29
25.71
-9.41%
35.42
35.20
0.62%
45.69
46.02
-0.72%
Tax
18.18
4.11
342.34%
7.59
5.40
40.56%
7.93
8.52
-6.92%
4.65
11.17
-58.37%
PAT
56.35
11.40
394.30%
15.70
20.31
-22.70%
27.49
26.69
3.00%
41.04
34.85
17.76%
PATM
9.88%
2.68%
3.24%
4.36%
5.68%
5.89%
9.97%
7.96%
EPS
1.03
0.20
415.00%
0.29
0.37
-21.62%
0.50
0.49
2.04%
0.75
0.64
17.19%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
1,950.59
1,805.69
1,811.58
1,690.43
1,417.53
1,546.83
1,188.06
853.07
768.54
606.51
595.47
Net Sales Growth
9.49%
-0.33%
7.17%
19.25%
-8.36%
30.20%
39.27%
11.00%
26.72%
1.85%
 
Cost Of Goods Sold
1,179.76
1,066.46
1,113.11
1,016.87
900.22
980.35
735.29
524.19
479.12
361.28
358.35
Gross Profit
770.83
739.24
698.47
673.56
517.31
566.47
452.77
328.87
289.42
245.23
237.12
GP Margin
39.52%
40.94%
38.56%
39.85%
36.49%
36.62%
38.11%
38.55%
37.66%
40.43%
39.82%
Total Expenditure
1,766.58
1,680.06
1,637.51
1,531.81
1,338.00
1,410.15
1,069.54
784.55
701.02
541.78
534.09
Power & Fuel Cost
-
44.90
40.62
34.09
23.78
18.93
13.00
12.56
13.18
11.08
9.84
% Of Sales
-
2.49%
2.24%
2.02%
1.68%
1.22%
1.09%
1.47%
1.71%
1.83%
1.65%
Employee Cost
-
232.74
208.91
181.47
154.68
164.25
135.59
109.91
95.36
76.53
69.69
% Of Sales
-
12.89%
11.53%
10.74%
10.91%
10.62%
11.41%
12.88%
12.41%
12.62%
11.70%
Manufacturing Exp.
-
125.33
102.62
95.75
91.70
98.99
67.21
48.92
31.28
16.21
22.36
% Of Sales
-
6.94%
5.66%
5.66%
6.47%
6.40%
5.66%
5.73%
4.07%
2.67%
3.76%
General & Admin Exp.
-
73.16
67.17
66.63
55.44
42.38
34.71
36.47
36.14
28.52
18.11
% Of Sales
-
4.05%
3.71%
3.94%
3.91%
2.74%
2.92%
4.28%
4.70%
4.70%
3.04%
Selling & Distn. Exp.
-
98.98
79.99
109.98
93.01
53.58
49.66
40.11
32.73
30.04
25.79
% Of Sales
-
5.48%
4.42%
6.51%
6.56%
3.46%
4.18%
4.70%
4.26%
4.95%
4.33%
Miscellaneous Exp.
-
38.50
25.09
27.02
19.17
51.67
34.08
12.39
13.20
18.11
25.79
% Of Sales
-
2.13%
1.38%
1.60%
1.35%
3.34%
2.87%
1.45%
1.72%
2.99%
5.03%
EBITDA
184.00
125.63
174.07
158.62
79.53
136.68
118.52
68.52
67.52
64.73
61.38
EBITDA Margin
9.43%
6.96%
9.61%
9.38%
5.61%
8.84%
9.98%
8.03%
8.79%
10.67%
10.31%
Other Income
22.09
21.31
18.36
13.97
6.13
20.10
12.07
9.48
3.67
3.72
3.72
Interest
17.22
16.41
8.34
3.71
1.98
2.43
1.79
1.98
2.11
4.36
7.56
Depreciation
35.76
36.43
28.98
33.47
27.93
27.64
30.28
36.91
39.90
34.32
33.90
PBT
178.93
94.09
155.11
135.42
55.76
126.70
98.51
39.11
29.18
29.77
23.63
Tax
38.35
24.27
37.09
38.80
17.08
25.02
1.42
5.53
0.34
0.00
0.00
Tax Rate
21.43%
20.24%
23.91%
28.65%
30.63%
19.75%
1.44%
14.14%
1.17%
0.00%
0.00%
PAT
140.58
94.88
118.03
96.16
38.68
101.68
97.09
33.58
28.85
29.59
23.63
PAT before Minority Interest
140.63
95.65
118.02
96.62
38.68
101.68
97.09
33.58
28.84
29.77
23.63
Minority Interest
0.05
-0.77
0.01
-0.46
0.00
0.00
0.00
0.00
0.01
-0.18
0.00
PAT Margin
7.21%
5.25%
6.52%
5.69%
2.73%
6.57%
8.17%
3.94%
3.75%
4.88%
3.97%
PAT Growth
50.76%
-19.61%
22.74%
148.60%
-61.96%
4.73%
189.13%
16.40%
-2.50%
25.22%
 
EPS
2.57
1.73
2.15
1.75
0.71
1.86
1.77
0.61
0.53
0.54
0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
1,246.44
1,156.23
847.23
752.91
578.56
424.75
284.06
253.09
225.94
196.26
Share Capital
109.58
109.58
102.23
102.23
95.56
89.96
89.96
89.96
89.96
89.96
Total Reserves
1,136.85
1,046.65
745.00
650.68
456.75
291.04
194.10
163.13
135.98
106.30
Non-Current Liabilities
198.73
90.49
43.93
36.88
35.50
30.06
28.42
23.38
20.20
17.80
Secured Loans
4.49
5.76
3.36
0.93
1.32
0.83
0.92
1.83
2.95
1.38
Unsecured Loans
129.11
20.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
41.24
39.85
33.82
29.74
28.24
25.39
23.82
19.01
14.42
13.59
Current Liabilities
490.30
500.65
402.04
321.16
456.46
403.80
351.44
339.17
340.12
324.86
Trade Payables
317.24
363.30
295.03
226.88
258.12
208.85
172.30
168.15
174.88
124.88
Other Current Liabilities
106.47
71.72
58.51
54.86
169.97
174.38
165.06
160.64
163.90
198.65
Short Term Borrowings
36.95
46.04
23.49
23.18
16.13
15.32
11.36
8.99
0.00
0.00
Short Term Provisions
29.64
19.60
25.02
16.24
12.24
5.25
2.72
1.39
1.33
1.33
Total Liabilities
1,936.12
1,778.10
1,293.20
1,110.49
1,070.06
858.15
663.46
615.18
585.81
538.29
Net Block
513.00
488.51
307.35
266.97
251.80
224.52
216.37
236.21
264.29
271.80
Gross Block
796.70
828.38
620.63
656.24
613.25
628.32
752.55
887.76
997.60
1,026.96
Accumulated Depreciation
283.70
339.87
313.28
389.27
361.45
403.79
536.18
651.55
733.31
755.15
Non Current Assets
772.51
618.73
404.16
354.33
335.75
331.36
291.29
315.71
342.37
346.34
Capital Work in Progress
21.55
28.34
24.45
17.01
14.15
1.96
0.00
0.00
0.00
0.00
Non Current Investment
101.29
7.17
1.30
0.00
0.00
1.08
1.08
0.00
0.00
0.00
Long Term Loans & Adv.
136.39
94.47
70.82
70.07
69.53
103.52
73.55
79.22
77.81
73.69
Other Non Current Assets
0.27
0.23
0.24
0.28
0.28
0.27
0.28
0.28
0.27
0.85
Current Assets
1,163.61
1,159.37
889.04
756.16
734.30
526.79
372.18
299.47
243.44
191.95
Current Investments
22.87
77.81
0.00
0.00
0.00
0.00
0.00
0.02
0.22
0.00
Inventories
271.83
299.96
248.59
228.89
275.85
175.33
138.48
94.20
76.89
64.66
Sundry Debtors
333.14
324.76
324.94
263.25
250.64
181.98
137.68
133.75
121.85
92.95
Cash & Bank
68.83
49.36
52.12
56.31
45.97
67.89
38.88
32.21
5.95
7.59
Other Current Assets
466.95
71.51
16.44
7.15
161.83
101.59
57.14
39.29
38.53
26.74
Short Term Loans & Adv.
360.43
335.97
246.96
200.58
156.54
91.58
51.16
31.43
33.61
23.43
Net Current Assets
673.31
658.72
487.00
435.00
277.84
122.99
20.73
-39.70
-96.68
-132.92
Total Assets
1,936.12
1,778.10
1,293.20
1,110.49
1,070.05
858.15
663.47
615.18
585.81
538.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
32.64
32.06
73.37
-91.17
-60.24
50.83
11.02
17.37
63.41
40.73
PBT
119.92
155.11
135.42
55.76
126.70
98.51
39.11
29.18
29.77
23.04
Adjustment
33.46
37.79
34.20
27.90
19.46
31.96
36.63
40.32
38.64
41.40
Changes in Working Capital
-95.46
-123.69
-58.12
-158.28
-181.47
-78.18
-58.84
-51.78
-5.00
-23.72
Cash after chg. in Working capital
57.92
69.21
111.49
-74.62
-35.31
52.29
16.89
17.71
63.41
40.73
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-25.28
-37.15
-38.12
-16.55
-24.93
-1.46
-5.88
-0.34
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-123.42
-321.51
-83.30
-46.51
-31.68
-70.35
-12.46
-13.05
-26.93
-13.60
Net Fixed Assets
3.97
-175.29
27.27
-35.47
24.52
123.41
135.60
113.16
31.96
-8.08
Net Investments
94.93
-78.80
-8.34
-0.05
0.99
0.00
-1.07
0.20
-0.22
0.00
Others
-222.32
-67.42
-102.23
-10.99
-57.19
-193.76
-146.99
-126.41
-58.67
-5.52
Cash from Financing Activity
97.40
299.89
5.20
143.54
66.33
47.27
5.49
-0.44
-37.77
-23.72
Net Cash Inflow / Outflow
6.62
10.44
-4.72
5.86
-25.58
27.75
4.04
3.88
-1.29
3.40
Opening Cash & Equivalents
27.38
16.95
21.67
15.80
41.39
13.64
9.60
5.72
7.00
3.60
Closing Cash & Equivalent
31.19
27.38
16.95
21.67
15.80
41.39
13.64
9.60
5.72
7.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
22.75
21.10
16.58
14.73
11.56
8.47
6.32
5.63
5.02
4.36
ROA
5.15%
7.68%
8.04%
3.55%
10.55%
12.76%
5.25%
4.80%
5.30%
4.45%
ROE
7.96%
11.78%
12.08%
5.93%
21.79%
29.20%
12.50%
12.04%
14.10%
12.54%
ROCE
10.19%
15.48%
16.82%
8.40%
24.86%
27.13%
12.05%
10.01%
14.05%
10.18%
Fixed Asset Turnover
2.22
2.50
2.65
2.23
2.49
1.72
1.04
0.82
0.60
0.58
Receivable days
66.49
65.45
63.50
66.16
51.04
49.10
58.07
60.70
64.63
55.44
Inventory Days
57.79
55.26
51.55
64.98
53.23
48.20
49.78
40.63
42.59
32.73
Payable days
116.46
107.94
93.67
98.32
86.93
94.60
79.06
88.85
103.38
82.97
Cash Conversion Cycle
7.82
12.78
21.38
32.82
17.35
2.71
28.78
12.48
3.85
5.20
Total Debt/Equity
0.16
0.07
0.03
0.03
0.03
0.04
0.05
0.52
0.06
0.25
Interest Cover
8.31
19.59
37.50
29.15
53.22
56.09
20.71
14.83
7.83
4.13

News Update:


  • Morepen Lab expands reactor capacity for API, CDMO
    7th Sep 2026, 11:14 AM

    The company has completed the first phase of its manufacturing capacity expansion program

    Read More
  • Morepen Laboratories - Quarterly Results
    5th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.